Hjem › Wilms tumor › Missouri
Kliniske studier for Wilms tumor i Missouri
4 studier for Wilms tumor søker deltakere på steder i Missouri.
Byer i Missouri
Offisiell studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Washington University School of Medicine, St Louis
RekruttererFase 2
Alder 12 til 39 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- University of Missouri Children's Hospital, Columbia
- Children's Mercy Hospitals and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- og 2 flere
RekruttererFase 2
Opp til 30 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Washington University School of Medicine, St Louis
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Washington University, St Louis
RekruttererFase 2
12 Months · Alle kjønn · Oppdatert 6. mai 2026 · NCT05985161Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.